Discriminative Accuracy of FEV1: FVC Thresholds for COPD-Related Hospitalization and Mortality

被引:151
|
作者
Bhatt, Surya P. [1 ,2 ]
Balte, Pallavi P. [3 ]
Schwartz, Joseph E. [3 ]
Cassano, Patricia A. [4 ]
Couper, David [5 ]
Jacobs, David R., Jr. [6 ]
Kalhan, Ravi [7 ]
O'Connor, George T. [8 ]
Yende, Sachin [9 ,10 ]
Sanders, Jason L. [11 ]
Umans, Jason G. [12 ]
Dransfield, Mark T. [1 ,2 ]
Chaves, Paulo H. [13 ]
White, Wendy B. [14 ]
Oelsner, Elizabeth C. [3 ,15 ]
机构
[1] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, THT 422,1720 Second Ave S, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL USA
[3] Columbia Univ, Med Ctr, Div Gen Med, 630 W 168th St,Presbyterian Hosp Ninth Floor, New York, NY 10032 USA
[4] Weill Cornell Med Coll, Div Nutr Sci, Ithaca, NY USA
[5] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
[8] Boston Univ, Div Pulm Allergy Sleep & Crit Care, Boston, MA 02215 USA
[9] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA
[10] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[11] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA
[12] MedStar Hlth Res Inst, Hyattsville, MD USA
[13] Florida Int Univ, Benjamin Leon Ctr Geriatr Res & Educ, Miami, FL 33199 USA
[14] Tougaloo Coll, Undergrad Training & Educ Ctr, Tougaloo, MS USA
[15] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
来源
关键词
OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; AMERICAN-COLLEGE; REFERENCE VALUES; TASK-FORCE; MANAGEMENT; DIAGNOSIS; LESS-THAN-0.70; ASSOCIATION; PREVENTION;
D O I
10.1001/jama.2019.7233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE According to numerous current guidelines, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV1: FVC) of less than 0.70, yet this fixed threshold is based on expert opinion and remains controversial. OBJECTIVE To determine the discriminative accuracy of various FEV1: FVC fixed thresholds for predicting COPD-related hospitalization and mortality. DESIGN, SETTING, AND PARTICIPANTS The National Heart, Lung, and Blood Institute (NHLBI) Pooled Cohorts Study harmonized and pooled data from 4 US general population-based cohorts (Atherosclerosis Risk in Communities Study; Cardiovascular Health Study; Health, Aging, and Body Composition Study; and Multi-Ethnic Study of Atherosclerosis). Participants aged 45 to 102 years were enrolled from 1987 to 2000 and received follow-up longitudinally through 2016. EXPOSURES Presence of airflow obstruction, which was defined by a baseline FEV1: FVC less than a range of fixed thresholds (0.75 to 0.65) or less than the lower limit of normal as defined by Global Lung Initiative reference equations (LLN). MAIN OUTCOMES AND MEASURES The primary outcome was a composite of COPD hospitalization and COPD-related mortality, defined by adjudication or administrative criteria. The optimal fixed FEV1: FVC threshold was defined by the best discrimination for these COPD-related events as indexed using the Harrell C statistic from unadjusted Cox proportional hazards models. Differences in C statistics were compared with respect to less than 0.70 and less than LLN thresholds using a nonparametric approach. RESULTS Among 24 207 adults in the pooled cohort (mean [SD] age at enrollment, 63 [10.5] years; 12 990 [54%] women; 16 794 [69%] non-Hispanic white; 15 181 [63%] ever smokers), complete follow-up was available for 11 077 (77%) at 15 years. During a median follow-up of 15 years, 3925 participants experienced COPD-related events over 340 757 person-years of follow-up (incidence density rate, 11.5 per 1000 person-years), including 3563 COPD-related hospitalizations and 447 COPD-related deaths. With respect to discrimination of COPD-related events, the optimal fixed threshold (0.71; C statistic for optimal fixed threshold, 0.696) was not significantly different from the 0.70 threshold (difference, 0.001 [95% CI, -0.002 to 0.004]) but was more accurate than the LLN threshold (difference, 0.034 [95% CI, 0.028 to 0.041]). The 0.70 threshold provided optimal discrimination in the subgroup analysis of ever smokers and in adjusted models. CONCLUSIONS AND RELEVANCE Defining airflow obstruction as FEV1: FVC less than 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different or was more accurate than other fixed thresholds and the LLN. These results support the use of FEV1: FVC less than 0.70 to identify individuals at risk of clinically significant COPD.
引用
收藏
页码:2438 / 2447
页数:10
相关论文
共 50 条
  • [31] FEV1/FVC Fixed Ratio Again!
    Fabbri, Leonardo M.
    CHEST, 2011, 139 (05) : 1252 - 1253
  • [32] COPD患者IOS测定的阻力指标与FEV1%、FEV1/FVC相关性分析
    姚颖
    杨军
    浙江实用医学, 2004, (03) : 9+25 - 9+25
  • [33] Rapid FEV1/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
    Choi, Kwang Yong
    Lee, Hyo Jin
    Lee, Jung-Kyu
    Park, Tae Yun
    Heo, Eun Young
    Kim, Deog Kyeom
    Lee, Hyun Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (01)
  • [34] Spirometry standards and FEV1/FVC repeatability
    Cooper, Brendan
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (03): : 292 - 294
  • [35] Should We Use FEV1/FVC
    Lamprecht, B.
    Schirnhofer, L.
    Kaiser, B.
    Studnicka, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [36] Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV1/FVC
    Kronborg, Thomas
    Hangaard, Stine
    Cichosz, Simon Lebech
    Hejlesen, Ole
    RESPIRATORY CARE, 2019, 64 (01) : 85 - 90
  • [37] FEV1 Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study
    Menezes, Ana Maria B.
    Perez-Padilla, Rogelio
    Wehrmeister, Fernando Cesar
    Lopez-Varela, Maria Victorina
    Muino, Adriana
    Valdivia, Gonzalo
    Lisboa, Carmen
    Jardim, Jose Roberto B.
    de Oca, Maria Montes
    Talamo, Carlos
    Bielemann, Renata
    Gazzotti, Mariana
    Laurenti, Ruy
    Celli, Bartolome
    Victora, Cesar G.
    PLOS ONE, 2014, 9 (10):
  • [38] COPD or not COPD: Answer in FEV1
    Guillien, Alicia
    Puyraveau, Marc
    Soumagne, Thibaud
    Veil-Picard, Matthieu
    Roux, Pauline
    Guillou, Stephanie
    Rannou, Fabrice
    Berger, Patrick
    Mauny, Frederic
    Laplante, Jean-Jacques
    Dalphin, Jean-Charles
    Degano, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC
    Saint-Pierre, Mathieu
    Ladha, Jamil
    Berton, Danilo
    Zapotichny, Angie
    Faubert, Denis
    Crozier-Wells, Lori
    Tang, Julianna
    Muir, Cathy
    Forkert, Lutz
    O'Donnell, Denis
    Serafini, Jose Alberto Neder
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [40] Low FEV1/FVC but normal FEV1 in childhood - risk factor or normal variant?
    Hallberg, Jenny
    Bergstrom, Anna
    Hellberg, Ulrika
    Kull, Inger
    Peterson, Eva
    Melen, Erik
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54